MSH2 and female reproductive organ cancer: Herein, we described that the risk of gynecological cancer was associated with MSH2 (log-rank test MLH1 vs. MSH2 p = 0.02) while no significant difference in CRC risk according to genotype was found (Figure 4C, Table 4).